TLGT Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Stats
Dzisiejszy wolumen	72.25M
Średni wolumen	7.97M
Kapitalizacja rynkowa	0.00
EPS	$-0.140 ( 2021-08-16 )
Last Dividend	$47.50 ( 1995-12-13 )
Next Dividend	$0 ( N/A )
P/E	-0.0403
ATR14	$0.0270 (15.56%)

Insider Trading

Date	Person	Action	Amount	type
2021-07-21	Ben-maimon Carole	Buy	150 000	Restricted Stock Units
2021-07-21	Celentano John E	Buy	150 000	Restricted Stock Units
2021-07-21	Marth William S	Buy	150 000	Restricted Stock Units
2021-07-21	Pate R Carter	Buy	150 000	Restricted Stock Units
2021-07-16	Yachmetz Philip K	Buy	7 835	Restricted Stock Units

INSIDER POWER
0.00
Last 94 transactions
Buy: 6 929 847 \| Sell: 975 703

Wolumen Korelacja

Długi: -0.41 (neutral)

Krótki: -0.94 (very strong negative)

Signal:(21.732) Possible Trading Opportunity Present (swing)

Teligent Inc (NEW JERSEY) Korelacja

10 Najbardziej pozytywne korelacje
SVAC	0.953
ALLR	0.946
AKTX	0.941
CWCO	0.936
PAIC	0.934
NMTR	0.933
APVO	0.932
CYRN	0.931
BOXL	0.928
FANH	0.928

10 Najbardziej negatywne korelacje
CSLM	-0.964
SCRM	-0.952
XPAX	-0.949
BOCN	-0.949
NETE	-0.948
XFIN	-0.947
AMTBB	-0.947
FEXD	-0.945
ALSA	-0.943
ALPN	-0.942

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Teligent Inc (NEW JERSEY) Korelacja - Waluta/Towar

-0.52
( weak negative )

-0.80
( strong negative )

0.00
( neutral )

-0.35
( neutral )

-0.32
( neutral )

0.76
( moderate )

Teligent Inc (NEW JERSEY) Finanse

Annual	2020
Przychody:	$45.31M
Zysk brutto:	$45.31M (100.00 %)
EPS:	$0

FY	2020
Przychody:	$45.31M
Zysk brutto:	$45.31M (100.00 %)
EPS:	$0

FY	2019
Przychody:	$65.90M
Zysk brutto:	$23.52M (35.70 %)
EPS:	$-4.70

FY	2017
Przychody:	$67.25M
Zysk brutto:	$27.37M (40.70 %)
EPS:	$-2.80

Financial Reports:

No articles found.

Teligent Inc (NEW JERSEY) Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Teligent Inc (NEW JERSEY) Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$47.50	1995-12-13
Last Dividend	$47.50	1995-12-13
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$47.50	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-05-03)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
1995	$0	0.00%
1996	$0	0.00%
1997	$0	0.00%
1998	$0	0.00%
1999	$0	0.00%
2000	$0	0.00%
2001	$0	0.00%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0	1.500	-1.111	-1.667	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.916	0.800	5.42	4.34	[1 - 3]
quickRatioTTM	0.744	0.800	-0.329	-0.263	[0.8 - 2.5]
cashRatioTTM	0.257	1.500	9.68	10.00	[0.2 - 2]
debtRatioTTM	1.636	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.217	2.00	-0.0725	-0.145	[0 - 30]
freeCashFlowPerShareTTM	-0.270	2.00	-0.135	-0.270	[0 - 20]
debtEquityRatioTTM	-1.246	-1.500	-4.98	7.47	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.988	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.122	1.000	-1.790	-1.790	[0.2 - 2]
assetTurnoverTTM	0.540	0.800	9.73	7.79	[0.5 - 2]
Total Score				3.69

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0	1.000	-0.101	0	[1 - 100]
returnOnEquityTTM	0	2.50	-0.714	-1.667	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.270	2.00	-0.0899	-0.270	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.217	2.00	-0.0725	-0.145	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.370	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-1.721

Teligent Inc (NEW JERSEY)

Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.